Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

Clinical trial NCT00161668 · COMPLETED

Trial details

NCT number: NCT00161668
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Myeloid Leukemia

Start date: 2001-10-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.